Bart Anthony Lutterbach, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2014 | 211 | 0.700 |
Why?
|
| Gene Amplification | 3 | 2014 | 1085 | 0.600 |
Why?
|
| Receptor, erbB-3 | 1 | 2008 | 143 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-met | 5 | 2013 | 567 | 0.280 |
Why?
|
| Cell Proliferation | 4 | 2014 | 10446 | 0.260 |
Why?
|
| Receptors, Growth Factor | 1 | 2007 | 326 | 0.260 |
Why?
|
| Benzocycloheptenes | 2 | 2013 | 9 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2007 | 4490 | 0.160 |
Why?
|
| Stomach Neoplasms | 1 | 2008 | 1423 | 0.150 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 16939 | 0.130 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2013 | 1613 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6853 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2013 | 5643 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2014 | 3607 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 5253 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 5251 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2013 | 256 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2014 | 642 | 0.100 |
Why?
|
| Cell Survival | 2 | 2014 | 5797 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2014 | 3584 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.090 |
Why?
|
| Pyrimidines | 2 | 2014 | 3016 | 0.080 |
Why?
|
| Image Cytometry | 1 | 2008 | 53 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 3442 | 0.080 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 384 | 0.070 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2008 | 267 | 0.070 |
Why?
|
| Dogs | 4 | 2013 | 3841 | 0.070 |
Why?
|
| Sulfonamides | 2 | 2013 | 1977 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2014 | 2488 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2448 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6216 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2013 | 1057 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2003 | 1596 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2011 | 8313 | 0.060 |
Why?
|
| Smooth Muscle Myosins | 1 | 2003 | 2 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 2053 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 13262 | 0.050 |
Why?
|
| Chromosome Inversion | 1 | 2003 | 120 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 279 | 0.050 |
Why?
|
| Apoptosis | 2 | 2008 | 9501 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2003 | 402 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3602 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 5799 | 0.040 |
Why?
|
| Haplorhini | 2 | 2011 | 529 | 0.040 |
Why?
|
| Pyridines | 1 | 2011 | 2879 | 0.040 |
Why?
|
| RNA, Double-Stranded | 1 | 2020 | 295 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2010 | 3610 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 2221 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2011 | 717 | 0.040 |
Why?
|
| Mice | 6 | 2020 | 81208 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13630 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2013 | 1792 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2003 | 3602 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2011 | 1982 | 0.030 |
Why?
|
| DNA-Binding Proteins | 2 | 2003 | 9585 | 0.030 |
Why?
|
| Repressor Proteins | 2 | 2003 | 2981 | 0.030 |
Why?
|
| Animals | 7 | 2020 | 167963 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3105 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2020 | 1411 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2003 | 1854 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2003 | 12103 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2011 | 3084 | 0.020 |
Why?
|
| Subcellular Fractions | 2 | 2003 | 532 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2013 | 5434 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6315 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2008 | 5351 | 0.020 |
Why?
|
| Humans | 13 | 2020 | 760621 | 0.020 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2003 | 351 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 426 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2013 | 23376 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 8986 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2010 | 706 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 670 | 0.020 |
Why?
|
| Neoplasms | 3 | 2013 | 22072 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 465 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 2014 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3844 | 0.020 |
Why?
|
| Automation | 1 | 2008 | 580 | 0.020 |
Why?
|
| Rats | 2 | 2013 | 23711 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2003 | 3800 | 0.020 |
Why?
|
| Protein Binding | 2 | 2011 | 9335 | 0.020 |
Why?
|
| Mutation | 4 | 2013 | 29932 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2013 | 3969 | 0.020 |
Why?
|
| Transfection | 2 | 2003 | 5781 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2506 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3735 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8515 | 0.010 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2003 | 20 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2379 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2002 | 228 | 0.010 |
Why?
|
| Ligands | 1 | 2008 | 3276 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 400 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2003 | 1085 | 0.010 |
Why?
|
| Dimerization | 1 | 2003 | 891 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 452 | 0.010 |
Why?
|
| COS Cells | 1 | 2003 | 1129 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18137 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1999 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2002 | 568 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 2907 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 1649 | 0.010 |
Why?
|
| Histone Deacetylases | 1 | 2003 | 718 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2275 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 1745 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1388 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 1964 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5206 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12808 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2651 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 2668 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6131 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 18957 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 6048 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9467 | 0.010 |
Why?
|
| Female | 4 | 2013 | 391270 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 8950 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 7593 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 169152 | 0.000 |
Why?
|
| Male | 1 | 2020 | 359744 | 0.000 |
Why?
|